NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025

Core Points - NewGenIvf Group Limited clarified that it has not yet achieved compliance with Nasdaq's $2.5 million minimum stockholders' equity requirement, although it believes it has exceeded this amount due to recent debt conversions and equity line drawdowns [1][2] - The Nasdaq Hearings Panel granted NewGen an extension to regain compliance with listing requirements, and the company has made progress, including a reverse stock split to meet the $1.00 bid price requirement [2] - NewGen operates as a comprehensive fertility services provider in Asia, with clinics in Thailand, Cambodia, and Kyrgyzstan, offering a range of infertility treatments and services [3]